The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 15, pp. 1406 - 1415
The anticoagulant edoxaban, an oral inhibitor of activated factor X, does not require monitoring. As initial treatment for acute venous thromboembolism,...
MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | DABIGATRAN | MANAGEMENT | STROKE PREVENTION | ACUTE PULMONARY-EMBOLISM | CLINICAL-TRIALS | DYSFUNCTION | FACTOR XA INHIBITOR | EPIDEMIOLOGY | ATRIAL-FIBRILLATION | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Kaplan-Meier Estimate | Warfarin - adverse effects | Anticoagulants - therapeutic use | Male | Enoxaparin - therapeutic use | Anticoagulants - adverse effects | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Female | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Warfarin | Usage | Anticoagulants (Medicine) | Venous thrombosis | Comparative analysis | Drug therapy | Health aspects | Heart | Creatinine | Brain natriuretic peptide | Anticoagulants | Embolisms | Body weight | Thrombosis | Patients | Bleeding | Embolism | Heparin | Ventricle | Thromboembolism | Veins & arteries | Enoxaparin | Hemorrhage | Life Sciences | Venous Thromboembolism | Pulmonary Embolism
MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | DABIGATRAN | MANAGEMENT | STROKE PREVENTION | ACUTE PULMONARY-EMBOLISM | CLINICAL-TRIALS | DYSFUNCTION | FACTOR XA INHIBITOR | EPIDEMIOLOGY | ATRIAL-FIBRILLATION | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Kaplan-Meier Estimate | Warfarin - adverse effects | Anticoagulants - therapeutic use | Male | Enoxaparin - therapeutic use | Anticoagulants - adverse effects | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Female | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Warfarin | Usage | Anticoagulants (Medicine) | Venous thrombosis | Comparative analysis | Drug therapy | Health aspects | Heart | Creatinine | Brain natriuretic peptide | Anticoagulants | Embolisms | Body weight | Thrombosis | Patients | Bleeding | Embolism | Heparin | Ventricle | Thromboembolism | Veins & arteries | Enoxaparin | Hemorrhage | Life Sciences | Venous Thromboembolism | Pulmonary Embolism
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 2/2018, Volume 38, Issue 2, pp. 181 - 189
Individuals with deep vein thrombosis (DVT) have an increased risk of pulmonary embolism (PE), death, and long-term thrombotic complications.To evaluate the...
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | REGRESSION | PROPHYLAXIS | RECURRENT VENOUS THROMBOEMBOLISM | METAANALYSIS | MOLECULAR-WEIGHT HEPARIN | STANDARD CLINICAL-PRACTICE | PHARMACOLOGY & PHARMACY | LONG-TERM TREATMENT | ADHERENCE | UNFRACTIONATED HEPARIN | PREDICTIVE FACTOR | Venous Thrombosis - diagnosis | Acute Disease | Anticoagulants - administration & dosage | Drug Administration Schedule | Venous Thrombosis - drug therapy | Humans | Middle Aged | Male | Warfarin - administration & dosage | Enoxaparin - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Heparin, Low-Molecular-Weight - administration & dosage | Drug Therapy, Combination | Anticoagulants | Embolisms | Mortality | Clinical trials | Systematic review | Thrombosis | Blood clots | Compression therapy | Ultrasonic imaging | Clinical medicine | Thromboembolism | Health risk assessment | Veins & arteries
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | REGRESSION | PROPHYLAXIS | RECURRENT VENOUS THROMBOEMBOLISM | METAANALYSIS | MOLECULAR-WEIGHT HEPARIN | STANDARD CLINICAL-PRACTICE | PHARMACOLOGY & PHARMACY | LONG-TERM TREATMENT | ADHERENCE | UNFRACTIONATED HEPARIN | PREDICTIVE FACTOR | Venous Thrombosis - diagnosis | Acute Disease | Anticoagulants - administration & dosage | Drug Administration Schedule | Venous Thrombosis - drug therapy | Humans | Middle Aged | Male | Warfarin - administration & dosage | Enoxaparin - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Heparin, Low-Molecular-Weight - administration & dosage | Drug Therapy, Combination | Anticoagulants | Embolisms | Mortality | Clinical trials | Systematic review | Thrombosis | Blood clots | Compression therapy | Ultrasonic imaging | Clinical medicine | Thromboembolism | Health risk assessment | Veins & arteries
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2010, Volume 140, pp. S45 - S45
Journal Article
06/2017
FIELD: medicine.SUBSTANCE: cut in the internal carotid artery mouth is carried out. An eversion endarterectomy from the internal carotid artery is performed...
SURGERY | DIAGNOSIS | HYGIENE | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES | IDENTIFICATION
SURGERY | DIAGNOSIS | HYGIENE | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES | IDENTIFICATION
Patent
10/2019
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to vascular surgery and neurology, and can be used for prediction of ischemic stroke outcome....
SURGERY | DIAGNOSIS | HYGIENE | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES | IDENTIFICATION
SURGERY | DIAGNOSIS | HYGIENE | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES | IDENTIFICATION
Patent
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.